REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2023 • LENSAR, Inc. • Surgical & medical instruments & apparatus
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”), pursuant to which the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement, to issue and sell to the Purchasers at the Closing (as defined in the Purchase Agreement) (i) an aggregate of 20,000 shares (the “Preferred Shares”) of a newly created series of preferred stock, with a stated value of $1,000 per share (the “Preferred Stock”), designated Series A Convertible Preferred Stock, which shall initially be convertible into 7,940,447 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”; the shares of Common Stock issuable upon conversion of the Preferred Shares referred to as the “Conversion Shares”), in accordance with the terms of the Company’s Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock (as
INDEMNIFICATION AGREEMENTIndemnification Agreement • August 26th, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [___________], 2020 between LENSAR, Inc., a Delaware corporation (the “Company”), and [name] (“Indemnitee”).
SALES AGREEMENTSales Agreement • April 8th, 2021 • LENSAR, Inc. • Surgical & medical instruments & apparatus • New York
LENSAR, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
TRANSITION SERVICES AGREEMENTTransition Services Agreement • October 2nd, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”) and LENSAR, Inc., a Delaware corporation (“LENSAR”). PDL and LENSAR are referred to herein individually as a “Party”, and collectively as the “Parties.”
SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC. AND LENSAR, INC. DATED AS OF SEPTEMBER 30, 2020Separation and Distribution Agreement • October 2nd, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
This Separation and Distribution Agreement (this “Agreement”) is dated as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and LENSAR, Inc, a Delaware corporation and a direct, majority-owned subsidiary of PDL (“LENSAR” and, together with PDL, the “Parties”).
TAX MATTERS AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC. AND LENSAR, INC. DATED AS OF SEPTEMBER 30, 2020Tax Matters Agreement • October 2nd, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
This Tax Matters Agreement (this “Agreement”) is dated as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and LENSAR, Inc, a Delaware corporation and a direct, majority-owned subsidiary of PDL (“LENSAR” and, together with PDL, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Section 1.1.
INDUSTRIAL REAL ESTATE LEASE DISCOVERY TECH CENTER ORLANDO, FLORIDA by and between CHALLENGER-DISCOVERY, LLC, Landlord and LENSAR, INC., Tenant July 30, 2010Lease • September 14th, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 15th, 2023 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 12, 2023, by and among LENSAR, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Development AgreementDevelopment Agreement • August 4th, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus
This Development Agreement (“Agreement”), is made and entered into, to be effective as of January 29, 2020 (the “Effective Date”), by and between LENSAR, Inc, a Delaware corporation having its principal place of business at 2800 Discovery Drive, Suite 100, Orlando, FL 32826 (“LENSAR”), and Oertli Instrumente AG, a Swiss corporation having a principal place of business at Hafnerwisenstrasse 4, 9442 Berneck, Switzerland (“Oertli”). LENSAR and Oertli may each be referred to individually as a “Party” and collectively as the “Parties.”
CONFIDENTIAL INFORMATION EXCLUSIVE LICENSE AGREEMENT Between DOUG PATTON AND OPTHALMIC SYNERGIES, LLC and LENSAR, Inc.Exclusive License Agreement • August 26th, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
This Exclusive License Agreement (the “Agreement”) is effective as of September 23, 2019 (the “Effective Date”) by and between Doug Patton and Ophthalmic Synergies, a limited liability company organized under the laws of Nevada and located at 3050 Pullman Street, Costa Mesa, CA 92626 (individually and collectively “LICENSOR”) and LENSAR Inc., a Delaware company having a principal place of business at 2800 Discovery Drive, Suite 100, Orlando, Florida 32836 (“LENSAR”). LICENSOR and LENSAR are referred to individually as a “Party” and collectively as the “Parties”.
FORM OF VOTING AGREEMENTForm of Voting Agreement • May 18th, 2023 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
This VOTING AGREEMENT (this “Agreement”), dated as of May 18, 2023, is entered into by and between the undersigned stockholder (the “Stockholder”) of LENSAR, Inc., a Delaware corporation (the “Company”), and the Company. The Company and the Stockholder are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
